Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock

Cited by (999)

Items 301–400 of 999

1. The Meta-Genome of Sepsis: Host Genetics, Pathogens and the Acute Immune Response
   John H. Boyd, James A. Russell, Christopher D. Fjell · 2014 · Journal of Innate Immunity
2. Low-dose vasopressin infusion results in increased mortality and cardiac dysfunction following ischemia-reperfusion injury in mice
   Toonchai Indrambarya, John H. Boyd, Yingjin Wang, Melissa K. McConechy, Keith R. Walley · 2009 · Critical Care
3. Acute Kidney Injury After Cardiac Surgery by Complete KDIGO Criteria Predicts Increased Mortality
   Liisa M. Petäjä, Suvi T. Vaara, Sasu Liuhanen, Raili Tuulikki Suojaranta-Ylinen, Leena H. Mildh, Sara Nisula, Anna‐Maija Korhonen, Kirsi‐Maija Kaukonen, Markku Salmenperä, Ville Pettilä · 2016 · Journal of Cardiothoracic and Vascular Anesthesia
4. Vasopressors and Inotropes in Sepsis
   Leeanne Stratton, David Berlin, John E. Arbo · 2016 · Emergency Medicine Clinics of North America
5. Sepsis-related mortality in 497 cases with blood culture-positive sepsis in an emergency department
   Juha Rannikko, Jaana Syrjänen, Tapio Seiskari, Janne Aittoniemi, Reetta Huttunen · 2017 · International Journal of Infectious Diseases
6. Reduction of the severe sepsis or septic shock associated mortality by reinforcement of the recommendations bundle: A multicenter study
   Jean‐Yves Lefrant, Laurent Müller, Alice Raillard, Boris Jung, L. Beaudroit, Laurent Favier, Bernardo Paim Cunha Masson, Geoffroy Dingemans, F. Thévenot, Dominique Selcer et al. · 2010 · Annales Françaises d Anesthésie et de Réanimation
7. Scandinavian SSAI clinical practice guideline on choice of first‐line vasopressor for patients with acute circulatory failure
   Morten Hylander Møller, Casper Claudius, Eija Junttila, Michael Haney, A. Oscarsson‐Tibblin, A. Haavind, Anders Perner · 2016 · Acta Anaesthesiologica Scandinavica
8. Sepsis-induced acute kidney injury
   Arghya Majumdar · 2010 · Indian Journal of Critical Care Medicine
9. Sepsis, Severe Sepsis, and Septic Shock
   Robert S. Munford, Anthony F. Suffredini · 2010 · Elsevier eBooks
10. Vitamin C supplementation in the critically ill: A systematic review and meta-analysis
    Zhang, Michael, Jativa, David F · 2018 · SAGE Open Medicine
11. Sepsis With Preexisting Heart Failure: Management of Confounding Clinical Features
    Timothy W. Jones, Susan Elizabeth Smith, Joseph S. Van Tuyl, Andrea N. Sikora · 2020 · Journal of Intensive Care Medicine
12. Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use
    Massimo Sartelli, Carlo Tascini, Federico Coccolini, Fabiana Dellai, Luca Ansaloni, Massimo M. Antonelli, Michele Bartoletti, Matteo Bassetti, Federico Boncagni, Massimo Carlini et al. · 2024 · World Journal of Emergency Surgery
13. IL17A genetic variation is associated with altered susceptibility to Gram-positive infection and mortality of severe sepsis
    Taka‐aki Nakada, James A. Russell, John H. Boyd, Keith R. Walley · 2011 · Critical Care
14. Low Low-Density Lipoprotein Levels Are Associated With, But Do Not Causally Contribute to, Increased Mortality in Sepsis*
    Keith R. Walley, John H. Boyd, HyeJin Julia Kong, James A. Russell · 2018 · Critical Care Medicine
15. Beneficial Effects of Vasopressin Compared With Norepinephrine on Renal Perfusion, Oxygenation, and Function in Experimental Septic Acute Kidney Injury
    Nobuki Okazaki, Naoya Iguchi, Roger G. Evans, Sally G. Hood, Rinaldo Bellomo, Clive Newton May, Yugeesh R. Lankadeva · 2020 · Critical Care Medicine
16. Renal Microcirculation Injury as the Main Cause of Ischemic Acute Kidney Injury Development
    Ewa Kwiatkowska, Sebastian Kwiatkowski, Violetta Dziedziejko, Izabela Tomasiewicz, Leszek Domański · 2023 · Biology
17. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (Chinese version)
    David Moher · 2010 · Journal of Chinese Integrative Medicine
18. Advances in the Management of Pediatric Pulmonary Hypertension
    Peter E. Oishi, Sanjeev A. Datar, Jeffrey R. Fineman · 2011 · Respiratory Care
19. Critical care of the end-stage liver disease patient awaiting liver transplantation
    James Y. Findlay, Oren K. Fix, Cathérine Paugam‐Burtz, Linda L. Liu, Puneet Sood, Stephen J. Tomlanovich, Jean C. Emond · 2011 · Liver Transplantation
20. Effects of vasopressinergic receptor agonists on sublingual microcirculation in norepinephrine-dependent septic shock
    Andrea Morelli, Abele Donati, Christian Ertmer, Sebastian Willy Rehberg, Tim Kampmeier, Alessandra Orecchioni, Alessandro Russo, Annalia D’Egidio, Giovanni Landoni, Maria Rita Lombrano et al. · 2011 · Critical Care
21. The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature
    Laurence W. Busse, Michael T. McCurdy, Osman Ali, Anna Hall, Huaizhen Chen, Marlies Ostermann · 2017 · Critical Care
22. The impact of perioperative transfusion of blood products on survival after pediatric liver transplantation
    Mirco Nacoti, Simone Cazzaniga, F. Lorusso, Luigi Naldi, Pietro Maria Brambillasca, Ariela Benigni, Vittorio Corno, M. Colledan, Ezio Bonanomi, Sergio Vedovati et al. · 2012 · Pediatric Transplantation
23. Vasoplegia in septic shock: Do we really fight the right enemy?
    Nivin Sharawy · 2013 · Journal of Critical Care
24. Vasopressors for hypotensive shock
    Gamper, Gunnar, Havel, Christof, Arrich, Jasmin, Losert, Heidrun, Pace, Nathan L, Müllner, Marcus, Herkner, Harald · 2016 · Cochrane Database of Systematic Reviews
25. A Clinical Update on Vasoactive Medication in the Management of Cardiogenic Shock
    Aditi Shankar, Gayathri Gurumurthy, Lakshmi Sridharan, Divya Gupta, William J. Nicholson, Wissam A. Jaber, Saraschandra Vallabhajosyula · 2022 · Clinical Medicine Insights Cardiology
26. Management of Sepsis and Septic Shock: What Have We Learned in the Last Two Decades?
    Shiwani Kamath, Hiba Hammad Altaq, Tony Abdo · 2023 · Microorganisms
27. Association of angiotensin II type 1 receptor-associated protein gene polymorphism with increased mortality in septic shock*
    Taka‐aki Nakada, James A. Russell, John H. Boyd, Luke McLaughlin, Emiri Nakada, Simone A. Thair, Hiroyuki Hirasawa, Shigeto Oda, Keith R. Walley · 2011 · Critical Care Medicine
28. Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure
    Alexandre Mebazaa, Pierre‐François Laterre, James A. Russell, Andreas Bergmann, Luciano Gattinoni, Étienne Gayat, Michael Oscar Harhay, Oliver Hartmann, Frauke Hein, Anne Louise Kjølbye et al. · 2016 · Journal of Intensive Care
29. Vasopressor Therapy and Blood Pressure Management in the Setting of Acute Kidney Injury
    Laurence W. Busse, Marlies Ostermann · 2019 · Seminars in Nephrology
30. Inotropes in cardiac patients: update 2011
    John Parissis, Pinelopi Rafouli‐Stergiou, Vassilios E. Stassinos, Panagiotis Psarogiannakopoulos, Alexandre Mebazaa · 2010 · Current Opinion in Critical Care
31. Endocrine dysfunction in sepsis: a beneficial or deleterious host response?
    Valeriu Gheorghiţă, Alina Elena Barbu, Monica Livia Gheorghiu, Florin Alexandru Căruntu · 2015 · GERMS
32. Methylene blue as a vasopressor: a meta-analysis of randomised trials
    Laura Pasin, Michele Umbrello, Teresa Greco, Massimo Zambon, Federico Pappalardo, Martina Crivellari, Giovanni Borghi, Andrea Morelli, Alberto Zangrillo, Giovanni Landoni · 2013 · Critical Care and Resuscitation
33. Mean perfusion pressure deficit during the initial management of shock—an observational cohort study
    Rakshit Panwar, Nicholas Lanyon, Andrew R. Davies, Michael Bailey, David V. Pilcher, Rinaldo Bellomo · 2013 · Journal of Critical Care
34. Cytokines and Signaling Molecules Predict Clinical Outcomes in Sepsis
    Christopher D. Fjell, Simone A. Thair, Joseph L. Hsu, Keith R. Walley, James A. Russell, John H. Boyd · 2013 · PLoS ONE
35. Cardiac Function and Dysfunction in Sepsis
    Kimberly E. Fenton, Margaret M. Parker · 2016 · Clinics in Chest Medicine
36. Epidemiology of Vasopressin Use for Adults with Septic Shock
    Emily Anne Vail, Hayley Beth Gershengorn, May S. Hua, Allan J. Walkey, Hannah Wunsch · 2016 · Annals of the American Thoracic Society
37. Heparin-binding protein (HBP) improves prediction of sepsis-related acute kidney injury
    Jonas Tverring, Suvi T. Vaara, Jane Fisher, Meri Poukkanen, Ville Pettilä, Adam Linder · 2017 · Annals of Intensive Care
38. Is Mortality a Useful Primary End Point for Critical Care Trials?
    Richard A. Veldhoen, Daniel William Howes, David M. Maslove · 2019 · CHEST Journal
39. Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: a prospective cohort study
    Brian J. Anderson, Carolyn S. Calfee, Kathleen D. Liu, John P. Reilly, Kirsten Neudoerffer Kangelaris, Michael G. S. Shashaty, Aili L. Lazaar, Andrew I. Bayliffe, Robert Gallop, Todd A. Miano et al. · 2019 · Critical Care
40. Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock
    Sebastian Willy Rehberg, Christian Ertmer, Gabriele Köhler, Hans-Ulrich Spiegel, Andrea Morelli, Matthias Lange, Katharina Moll, Katrin Schlack, Hugo Van Aken, Fuhong Su et al. · 2009 · Intensive Care Medicine
41. Mixed Cardiogenic Shock: A Proposal for Standardized Classification, a Hemodynamic Definition, and Framework for Management
    Sean van Diepen, Janine Pöss, Janek Manoj Senaratne, Ann Gage, David A. Morrow · 2024 · Circulation
42. Effects of terlipressin on patients with sepsis via improving tissue blood flow
    Xudong Xiao, Jie Zhang, Yaoli Wang, Jian Zhou, Yu Zhu, Dongpo Jiang, Liangming Liu, Tao Li · 2015 · Journal of Surgical Research
43. A Functional Synonymous Coding Variant in the IL1RN Gene Is Associated with Survival in Septic Shock
    Nuala J. Meyer, Jane F. Ferguson, Rui Feng, Fan Wang, Parth N. Patel, Mingyao Li, Chenyi Xue, Liming Qu, Yichuan Liu, John H. Boyd et al. · 2014 · American Journal of Respiratory and Critical Care Medicine
44. Impact of endotracheal intubation on septic shock outcome: A post hoc analysis of the SEPSISPAM trial
    Agathe Delbove, Cédric Darreau, Jean François Hamel, Pierre Asfar, Nicolas Lerolle · 2015 · Journal of Critical Care
45. Trends in Use of Midodrine in the ICU: A Single-Center Retrospective Case Series
    Mahrukh S. Rizvi, Vrinda Trivedi, Faria Nasim, Erica Lin, Rahul Kashyap, Nicole M. Andrijasevic, Ognjen Gajic · 2018 · Critical Care Medicine
46. Basic Physiology for Anaesthetists
    David Chambers, Christopher L.-H. Huang, Gareth D. K. Matthews · 2019 · Cambridge University Press eBooks
47. Hemodynamic support in the early phase of septic shock: a review of challenges and unanswered questions
    Olivier Lesur, Eugénie Delile, Pierre Asfar, Peter Radermacher · 2018 · Annals of Intensive Care
48. A Single Nucleotide Polymorphism in NF-κB Inducing Kinase Is Associated with Mortality in Septic Shock
    Simone A. Thair, Keith R. Walley, Taka‐aki Nakada, Melissa K. McConechy, John H. Boyd, Hugh Wellman, James A. Russell · 2011 · The Journal of Immunology
49. Multicenter, Randomized, Placebo-Controlled Phase III Study of Pyridoxalated Hemoglobin Polyoxyethylene in Distributive Shock (PHOENIX)*
    Jean‐Louis Vincent, Christopher T. Privalle, Mervyn Singer, José A. Lorente, Erwin Boehm, Andreas Meier‐Hellmann, Harald Darius, Ricard Ferrer, Josep-María Sirvent, Gernot Marx et al. · 2014 · Critical Care Medicine
50. Epidemiology of Sepsis in Surgical Patients
    Laura J. Moore, Frederick Alan Moore · 2012 · Surgical Clinics of North America
51. Transfusion requirements in septic shock (TRISS) trial - comparing the effects and safety of liberal versus restrictive red blood cell transfusion in septic shock patients in the ICU: protocol for a randomised controlled trial
    Lars Broksø Holst, Nicolai Haase, Jørn Wetterslev, Jan Wernerman, Anders Åneman, Anne Berit Guttormsen, Pär I. Johansson, Sari Karlsson, Gudmundur Klemenzson, Robert Winding et al. · 2013 · Trials
52. The implications and management of septic acute kidney injury
    Zaccaria Ricci, Andréa Polito, Angelo Polito, Claudio Ronco · 2011 · Nature Reviews Nephrology
53. Raised cardiac troponin in intensive care patients with sepsis, in the absence of angiographically documented coronary artery disease: A systematic review
    Vasileios Zochios, Kamen P. Valchanov · 2014 · Journal of the Intensive Care Society
54. New, Potent, Selective, and Short-Acting Peptidic V1aReceptor Agonists
    Kazimierz Wiśniewski, Robert Galyean, Hiroe Tariga, Sudarkodi Alagarsamy, Glenn E Croston, Joshua Heitzmann, Arash Kohan, Halina Wiśniewska, Régent Laporte, Pierre J.-M. Rivière et al. · 2011 · Journal of Medicinal Chemistry
55. Temporal trends in the utilization of vasopressors in intensive care units: an epidemiologic study
    Charat Thongprayoon, Wisit Cheungpasitporn, Andrew M. Harrison, Perliveh Carrera, Narat Srivali, Wonngarm Kittamongkolchai, Ayşen Erdoğan, KIANOUSH B KASHANI · 2016 · BMC Pharmacology and Toxicology
56. Prevention and Therapy of Acute Kidney Injury in the Developing World
    Vijay Kher, Nattachai Srisawat, Eisei Noiri, Mohammed Benghanem Gharbi, Manjunath Sanjeeva Shetty, Li Yang, Arvind Bagga, Rajasekara M. Chakravarthi, Ravindra L. Mehta · 2017 · Kidney International Reports
57. Hyperoxia toxicity in septic shock patients according to the Sepsis-3 criteria: a post hoc analysis of the HYPER2S trial
    Julien Demiselle, Martin Wepler, Clair Hartmann, Peter Radermacher, Frédérique Schortgen, Ferhat Meziani, Mervyn Singer, Valérie Seegers, Pierre Asfar · 2018 · Annals of Intensive Care
58. The association of early postoperative desaturation in the operating theatre with hospital discharge to a skilled nursing or long‐term care facility
    Paul Rostin, Bijan J. Teja, Sabine Friedrich, Shahzad Shaefi, Kadhiresan R. Murugappan, Satya Krishna Ramachandran, Timothy T. Houle, Matthias Eikermann · 2019 · Anaesthesia
59. Interpretation of blood pressure signal: physiological bases, clinical relevance, and objectives during shock states
    Jean‐François Augusto, Jean–Louis Teboul, Peter Radermacher, Pierre Asfar · 2010 · Intensive Care Medicine
60. Vasopressor and Inotropic Management Of Patients With Septic Shock.
    Sacha R. Pollard, Stephanie B. Edwin, Cesar Alaniz · 2015 · PubMed Central
61. Efficacy and Safety of the Early Addition of Vasopressin to Norepinephrine in Septic Shock
    Drayton A. Hammond, Julia Cullen, Jacob T. Painter, Kelsey McCain, Oktawia A. Clem, Amy L. Brotherton, Divyan Chopra, Nikhil K. Meena · 2017 · Journal of Intensive Care Medicine
62. Vasopressin decreases sepsis-induced pulmonary inflammation through the V2R
    John H. Boyd, Cheryl Lynn Holmes, Yingjin Wang, Haley Roberts, Keith R. Walley · 2008 · Resuscitation
63. Pharmacologic therapies for acute cardiogenic shock
    Jose N. Nativi-Nicolau, Craig H. Selzman, James C. Fang, Josef Stehlik · 2014 · Current Opinion in Cardiology
64. Concomitant arginine-vasopressin and hydrocortisone therapy in severe septic shock: association with mortality
    Christian Torgersen, Günter Luckner, Daniel C. H. Schröder, Christian A. Schmittinger, Christopher S. Rex, Hanno Ulmer, Martin W. Dünser · 2011 · Intensive Care Medicine
65. Mortality benefit of vasopressor and inotropic agents in septic shock: A Bayesian network meta-analysis of randomized controlled trials
    Yuji Oba, Nazir Lone · 2014 · Journal of Critical Care
66. Inotrope and Vasopressor Therapy of Septic Shock
    Steven M. Hollenberg · 2009 · Critical Care Clinics
67. Multimodal strategy to counteract vasodilation in septic shock
    Marc Léone, Sharon Einav, Elio Antonucci, François Dépret, Inès Lakbar, Ignacio Martín‐Loeches, Patrick M. Wieruszewski, Sheila Nainan Myatra, Ashish Kumar Khanna · 2023 · Anaesthesia Critical Care & Pain Medicine
68. Effects of combined arginine vasopressin and levosimendan on organ function in ovine septic shock*
    Sebastian Willy Rehberg, Christian Ertmer, Jean‐Louis Vincent, Hans Ullrich Spiegel, Gabriele Köhler, Michael Erren, Matthias Lange, Andrea Morelli, Jennifer Seisel, Fuhong Su et al. · 2010 · Critical Care Medicine
69. Role of selective V1a receptor agonism in ovine septic shock*
    Sebastian Willy Rehberg, Christian Ertmer, Jean‐Louis Vincent, Andrea Morelli, Mareike Schneider, Matthias Lange, Hugo Van Aken, Daniel Lee Traber, Martin Westphal · 2010 · Critical Care Medicine
70. Vasopressin in Hemorrhagic Shock: A Systematic Review and Meta-Analysis of Randomized Animal Trials
    Andrea Pasquale Cossu, Paolo Mura, L.M. De Giudici, D Puddu, Laura Pasin, Maurizio Evangelista, Theodoros T Xanthos, Mario Musu, Gabriele Finco · 2014 · BioMed Research International
71. Selective V1aagonism attenuates vascular dysfunction and fluid accumulation in ovine severe sepsis
    Sebastian Willy Rehberg, Yusuke Yamamoto, Linda Elias Sousse, Éva Bartha, Collette Jonkam, Anthony K. Hasselbach, Lillian D. Traber, Robert A. Cox, Martin Westphal, Perenlei Enkhbaatar et al. · 2012 · American Journal of Physiology-Heart and Circulatory Physiology
72. Vasopressin Decreases Pulmonary–to–Systemic Vascular Resistance Ratio in a Porcine Model of Severe Hemorrhagic Shock
    Joy Sarkar, Patrick Golden, Lauren N. Kajiura, Lee‐Ann M Murata, CATHERINE F. T. UYEHARA · 2015 · Shock
73. Intensity of Vasopressor Therapy for Septic Shock and the Risk of In-Hospital Death
    Donald A. Brand, Patricia A. Patrick, Jeffrey Todd Berger, Mediha Ibrahim, Ajsza Matela, Shweta Upadhyay, Peter A. Spiegler · 2017 · Journal of Pain and Symptom Management
74. Estimating attributable fraction of mortality from sepsis to inform clinical trials
    Manu Shankar‐Hari, David A Harrison, Kathy Rowan, Gordon David Rubenfeld · 2018 · Journal of Critical Care
75. Management of acute-on-chronic liver failure: an algorithmic approach
    Shiv Kumar Sarin, Ashok Kumar Choudhury · 2018 · Hepatology International
76. Impact of PCSK9 loss-of-function genotype on 1-year mortality and recurrent infection in sepsis survivors
    Kelly R. Genga, Cody Lo, Mihai S. Cirstea, Fernando Sergio Leitão Filho, Keith R. Walley, James A. Russell, Adam Linder, Gordon A. Francis, John H. Boyd · 2018 · EBioMedicine
77. Reversal of Vasodilatory Shock: Current Perspectives on Conventional, Rescue, and Emerging Vasoactive Agents for the Treatment of Shock
    Jonathan H. Chow, Ezeldeen Abuelkasem, Susan K. Sankova, Reney A. Henderson, Michael A. Mazzeffi, Kenichi A. Tanaka · 2019 · Anesthesia & Analgesia
78. Catecholaminergic Vasopressors Reduce Toll-Like Receptor Agonist-Induced Microvascular Endothelial Cell Permeability But Not Cytokine Production
    Jérémie Joffre, Elliot Lloyd, Erika Wong, Che Chung-Yeh, Nina Nguyen, Fenguyn Xu, Matthieu M. Legrand, Judith Hellman · 2021 · Critical Care Medicine
79. The Surviving Sepsis Campaign: Fluid Resuscitation and Vasopressor Therapy Research Priorities in Adult Patients
    Ishaq Lat, Craig M. Coopersmith, Daniel De Backer · 2021 · Critical Care Medicine
80. Section 3: Prevention and Treatment of AKI
    2012 · Kidney International Supplements
81. Machine-learning-derived sepsis bundle of care
    Alexandre Kalimouttou, Ivan Lerner, Chérifa Cheurfa, Anne‐Sophie Jannot, Romain Pirracchio · 2022 · Intensive Care Medicine
82. Early vasopressin reduces incidence of new onset arrhythmias
    David P. Reardon, Jeremy R. DeGrado, Kevin E. Anger, Paul M. Szumita · 2014 · Journal of Critical Care
83. Role of Peroxynitrite in the Cardiovascular Dysfunction of Septic Shock
    Lucas Liaudet, Nathalie Rosenblatt‐Velin, Pál Pacher · 2013 · Current Vascular Pharmacology
84. Comparative efficacy of vasoactive medications in patients with septic shock: a network meta-analysis of randomized controlled trials
    Lu Cheng, Jing Yan, Shutang Han, Qiuhua Chen, Mingqi Chen, Hua Jiang, Jun Lü · 2019 · Critical Care
85. Heart Dysfunction in Sepsis
    Ricardo Poveda Jaramillo · 2020 · Journal of Cardiothoracic and Vascular Anesthesia
86. Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials
    Shalini Santhakumaran, Anthony C. Gordon, Andrew Toby Prevost, Cecilia M. O’Kane, Daniel Francis McAuley, Manu Shankar‐Hari · 2019 · Critical Care
87. Hemodynamic Instability During Liver Transplantation in Patients With End-stage Liver Disease: A Consensus Document from ILTS, LICAGE, and SATA
    Dmitri S. Bezinover, Ahmed Mohammed Mukhtar, Gebhard Wagener, Christopher L. Wray, Annabel Blasi, Kate Kronish, Jeron Zerillo, Dana Rodica Tomescu, Aliaksei Pustavoitau, Marina Gitman et al. · 2021 · Transplantation
88. Kidney Dysfunction After Traumatic Brain Injury: Pathophysiology and General Management
    Greet De Vlieger, Geert Meyfroidt · 2022 · Neurocritical Care
89. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
    Nobuaki Shime, Taka-aki Nakada, Tomoaki Yatabe, Kazuma Yamakawa, Yoshitaka Aoki, Shigeaki Inoue, Toshiaki Iba, Hiroshi Ogura, Yusuke Kawai, Atsushi Kawaguchi et al. · 2025 · Journal of Intensive Care
90. Discontinuation of vasopressin before norepinephrine increases the incidence of hypotension in patients recovering from septic shock: A retrospective cohort study
    Seth R. Bauer, Joseph J. Aloi, Christine L. Ahrens, Jun‐Yen Yeh, Daniel A. Culver, Anita J Reddy · 2009 · Journal of Critical Care
91. Early Diagnosis and Evidence-Based Care of Surgical Sepsis
    Laura J. Moore, Frederick Alan Moore · 2011 · Journal of Intensive Care Medicine
92. Adrenergic Downregulation in Critical Care: Molecular Mechanisms and Therapeutic Evidence
    Alessandro Belletti, Giovanni Landoni, В. В. Ломиворотов, Alessandro Oriani, Silvia Ajello · 2019 · Journal of Cardiothoracic and Vascular Anesthesia
93. Landmark survival as an end-point for trials in critically ill patients – comparison of alternative durations of follow-up: an exploratory analysis
    Gopal Taori, Kwok Ming Ho, Carol George, Rinaldo Bellomo, Steven A. R. Webb, Graeme K. Hart, Michael Bailey · 2009 · Critical Care
94. Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases
    Jun Xu, Hongliu Cai, Xia Zheng · 2023 · BMC Infectious Diseases
95. Molecular Mechanisms of Sepsis
    James A. Russell, John H. Boyd, Taka Nakada, Simone A. Thair, Keith R. Walley · 2011 · Contributions to microbiology
96. The Management of Severe Sepsis and Septic Shock
    Matthew R. Morrell, Scott T. Micek, Marin H. Kollef · 2009 · Infectious Disease Clinics of North America
97. Vasopressin: A Review of Therapeutic Applications
    Natalie F. Holt, Kenneth L. Haspel · 2009 · Journal of Cardiothoracic and Vascular Anesthesia
98. Osmoregulation of vasopressin secretion is altered in the postacute phase of septic shock*
    Shidasp Siami, Juliette Bailly-Salin, Andréa Polito, Raphaël Porcher, Anne Blanchard, Jean‐Philippe Haymann, Kathleen Laborde, Virginie Maxime, Catherine Boucly, Robert‐Yves Carlier et al. · 2010 · Critical Care Medicine
99. Pharmacological Characterization of FE 202158, a Novel, Potent, Selective, and Short-Acting Peptidic Vasopressin V1a Receptor Full Agonist for the Treatment of Vasodilatory Hypotension
    Régent Laporte, Arash Kohan, Joshua Heitzmann, Halina Wiśniewska, Jeannine Toy, Erin La, Hiroe Tariga, Sudarkodi Alagarsamy, Brian Ly, John Dykert et al. · 2011 · Journal of Pharmacology and Experimental Therapeutics
100. Misdirected Sympathy: The Role of Sympatholysis in Sepsis and Septic Shock
     Jason Ferreira, Brittany D. Bissell · 2017 · Journal of Intensive Care Medicine